• Small Molecules
    • Biologics
    • Other Drug Modalities
    • SynVent Integrated Drug Discovery
      • SynVent Integrated Drug Discovery

        SynVent is Syngene’s platform for fully integrated therapeutic discovery and development across large and small molecules. 

    • Industries
    • Emerging Biopharma
      • Emerging Biopharma

        Emerging biopharma work at the forefront of science, often venturing into disease areas where little or no real-world data exists to work with or regulatory frameworks to work within.

    • Dedicated Centers
      • Dedicated Centers

        Our Dedicated Centers offer dedicated multi-disciplinary scientific teams, support personnel, and a tailormade ring-fenced and fire-walled infrastructure as per client specifications to support their  R&D  goals

    • Center for Advanced Protein Studies (CAPS)
      • Center for Advanced Protein Studies (CAPS)

        Centre for Advanced Protein Studies [CAPS] is a state-of-the-art advanced national facility located in the Syngene campus, Bangalore.

  • Careers

Media Articles

Explore insightful coverage and perspectives on Syngene from various media outlets.
Accelerating Hope: How Strategic Partnerships Are Transforming Lung Cancer Drug Development
4th Aug, 2025
Syngene: How soon can it overcome near-term worries?
29th Jul, 2025
CDMOs gear up for peptide boom amid rising demand for weight-loss drugs
20th Jul, 2025
Sustainability is Becoming the Standard in Pharma Manufacturing
10th Jul, 2025
Strategic shifts position India as a pharma partner of choice
1st Jul, 2025
India enjoys a far greater degree of confidence in IP security for Western partners than does China
30th Jun, 2025

To view or email, Please share your details view

Your browser does not support this function.

To download, Please share your details

To view or email, Please share your details view

To download, Please share your details